Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

CYCLOPHARM LIMITED Director's Dealing 2007

Feb 11, 2007

64741_rns_2007-02-11_0e2e8aba-e32a-49d4-8760-f4d0b5cc3193.pdf

Director's Dealing

Open in viewer

Opens in your device viewer

Rule 3.19A.1

Appendix 3X

Initial Director's Interest Notice

Name of entity CYCLOPHARM LIMITED
ABN 74 116 931 250

We (the entity) give ASX the following information under listing rule 3.19A.1 and as agent for the director for the purposes of section 205G of the Corporations Act.

Name of Director David James Heaney
Date of appointment 20/11/2006

Part 1 - Director's relevant interests in securities of which the director is the registered holder

Number & class of securities
Ordinary Shares
Nil
Direct: Nil

$\overline{\text{+ See chapter 19}}$ for defined terms.

Part 2 – Director's relevant interests in securities of which the director is not the registered holder

In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust

Name of holder & nature of interest Number & class of Securities
Mr David James Heaney & Mr Andrew
٠
James Heaney
Ordinary Shares 172,500
Indirect 172,500
Total (Direct & Indirect): 172,500

Part 3 – Director's interests in contracts

Note: In the case of a company, interests which come within paragraph (ii) of the definition of "notiffable interest of a director" should be disclosed in this part.

Detail of contract Nil
Nature of interest
Name of registered holder
(if issued securities)
No. and class of securities to
which interest relates

$\overline{\text{+ See chapter 19}}$ for defined terms.